即时凝血检测设备市场－全球产业规模、份额、趋势、机会和预测（按设备类型、按产品、按最终用户、按地区和按竞争细分，2020-2030 年）

2024年，全球即时凝血检测设备市场规模达18.4亿美元，预计2030年将达25.8亿美元，预测期内复合年增长率为5.79%。受深部静脉血栓形成 (DVT)、肺栓塞、心肌梗塞、血友病和血管性血友病等血栓和出血性疾病盛行率不断上升的推动，该市场正经历着强劲增长势头。

由于人口老化和生活方式相关因素，这些疾病日益普遍，需要频繁且及时地监测凝血功能，尤其是在接受长期抗凝血治疗的患者中。急诊室、外科病房、抗凝血诊所和家庭医疗保健对快速诊断的需求，推动了对能够在几分钟内提供准确结果的即时诊断 (POC) 凝血设备的需求。

推动这一市场发展的显着趋势是医疗保健产业正转向分散式诊断，更青睐便携式、易于使用的设备，而非传统的集中式实验室检测。这种转变正在增强临床决策能力，最大限度地减少手术延误，并改善各种护理环境中的患者护理。

关键市场驱动因素

心血管和止血疾病盛行率上升

主要市场挑战

设备和耗材成本高

主要市场趋势

数位连接和远距医疗解决方案的集成

与这些设备配对的智慧型手机应用程式提供：

• 指导测试程序
• 结果视觉化展示
• 趋势分析
• 即时警报和通知

目录

第 1 章：产品概述

第二章：研究方法

第三章：执行摘要

第四章：顾客之声

第五章：全球即时凝血检测设备市场展望

• 市场规模和预测
  • 按价值
• 市场占有率和预测
  • 依设备类型（抗凝血监测设备、血小板功能监测设备、黏弹性凝血监测设备、其他）
  • 按产品（仪器/分析仪、耗材及配件）
  • 按最终使用者（医院、诊所、家庭护理机构、其他）
  • 按公司分类（2024）
  • 按地区
• 市场地图

第六章：北美即时凝血检测设备市场展望

• 市场规模和预测
• 市场占有率和预测
• 北美：国家分析
  • 美国
  • 墨西哥
  • 加拿大

第七章：欧洲即时凝血检测设备市场展望

• 市场规模和预测
• 市场占有率和预测
• 欧洲：国家分析
  • 法国
  • 德国
  • 英国
  • 义大利
  • 西班牙

第八章：亚太地区即时凝血检测设备市场展望

• 市场规模和预测
• 市场占有率和预测
• 亚太地区：国家分析
  • 中国
  • 印度
  • 韩国
  • 日本
  • 澳洲

第九章：南美洲即时凝血检测设备市场展望

• 市场规模和预测
• 市场占有率和预测
• 南美洲：国家分析
  • 巴西
  • 阿根廷
  • 哥伦比亚

第 10 章：中东和非洲即时凝血检测设备市场展望

• 市场规模和预测
• 市场占有率和预测
• MEA：国家分析
  • 南非
  • 沙乌地阿拉伯
  • 阿联酋

第 11 章：市场动态

• 驱动程式
• 挑战

第 12 章：市场趋势与发展

• 合併与收购（如有）
• 产品发布（如有）
• 最新动态

第十三章：干扰：衝突、流行病与贸易壁垒

第 14 章：波特五力分析

• 产业竞争
• 新进入者的潜力
• 供应商的力量
• 顾客的力量
• 替代产品的威胁

第 15 章：竞争格局

• F. Hoffmann-La Roche Ltd.
• Abbott Laboratories
• Werfen, SA
• Siemens Healthineers
• Helena Laboratories Corporation
• Medtronic plc
• Koninklijke Philips NV
• Alere Inc.
• HemoSonics, LLC
• Sysmex Corporation

第 16 章：策略建议

第17章调查会社について・免责事项

The Global Point of Care Coagulation Testing Devices Market was valued at USD 1.84 Billion in 2024 and is projected to reach USD 2.58 Billion by 2030, growing at a CAGR of 5.79% during the forecast period. This market is experiencing strong momentum, driven by the growing prevalence of thrombotic and bleeding disorders such as deep vein thrombosis (DVT), pulmonary embolism, myocardial infarction, hemophilia, and von Willebrand disease.

These conditions, increasingly common due to aging populations and lifestyle-related factors, demand frequent and timely coagulation monitoring-especially among patients undergoing long-term anticoagulant therapies. The need for rapid diagnostics in emergency rooms, surgical units, anticoagulation clinics, and home healthcare is fueling demand for point of care (POC) coagulation devices that deliver accurate results in minutes.

A notable trend driving this market is the healthcare industry's shift toward decentralized diagnostics, favoring portable, easy-to-use devices over traditional, centralized lab testing. This transformation is enhancing clinical decision-making, minimizing procedural delays, and improving patient care across a variety of care settings.

Key Market Drivers

Rising Prevalence of Cardiovascular and Hemostatic Disorders

The rising burden of cardiovascular diseases (CVDs) and hemostatic disorders is a primary growth catalyst. According to the World Health Organization, CVDs are responsible for approximately 17.9 million deaths annually, accounting for 32% of all global fatalities. One-third of these occur prematurely, before the age of 70.

In the United States alone, CVDs caused 930,000 deaths in 2020, making them the leading cause of mortality. Similarly, 2.2 million deaths across the Americas in 2021 were attributed to cardiovascular conditions. Despite a decline in mortality rates over recent decades, the absolute number of cases remains high, driven by aging populations and lifestyle-related risk factors.

Key Market Challenges

High Cost of Devices and Consumables

One of the most significant barriers to market growth is the high cost associated with POC coagulation testing systems. These devices often involve substantial upfront capital investment, particularly when equipped with wireless connectivity, data integration tools, and automated features.

Recurring expenses on test cartridges, reagents, maintenance, and software updates further strain hospital and clinic budgets-particularly in low-resource settings and developing regions. For home users, the cost of consumables over time can lead to reduced testing frequency or non-compliance, which compromises treatment safety and outcomes.

In public healthcare systems where budgets are constrained, procurement decisions often prioritize cost over long-term clinical value. Reimbursement inconsistencies further discourage adoption of these technologies in outpatient and remote care environments. Additionally, premium-priced consumables for advanced coagulation tests such as TEG and ROTEM are often limited to larger, better-funded hospitals.

Key Market Trends

Integration of Digital Connectivity and Telehealth Solutions

One of the most transformative trends reshaping this market is the digital evolution of POC coagulation devices. Modern analyzers now feature Bluetooth and Wi-Fi capabilities, allowing for instant transmission of results to electronic health record (EHR) systems or secure cloud platforms.

This connectivity enables remote patient monitoring, particularly for individuals on anticoagulants such as warfarin or DOACs. Physicians can monitor INR/PT levels in real time, adjust dosages, and enhance treatment compliance-all without in-person visits.

Smartphone apps paired with these devices offer:

• Guided test procedures
• Visual display of results
• Trend analysis
• Real-time alerts and notifications

This ecosystem supports telehealth platforms, enabling virtual consultations and improving access in rural or home-based settings. Remote diagnostics, firmware updates, and device troubleshooting via apps are also streamlining usability and reducing support burdens.

Key Market Players

• F. Hoffmann-La Roche Ltd.
• Abbott Laboratories
• Werfen, S.A.
• Siemens Healthineers
• Helena Laboratories Corporation
• Medtronic plc
• Koninklijke Philips N.V.
• Alere Inc.
• HemoSonics, LLC
• Sysmex Corporation

Market Segmentation

By Device Type:

• Anticoagulation Monitoring Devices
• Platelet Function Monitoring Devices
• Viscoelastic Coagulation Monitoring Devices
• Others

By Product:

• Instruments/Analyzers
• Consumables & Accessories

By End User:

• Hospitals
• Clinics
• Home Care Settings
• Others

By Region:

• North America
• United States
• Canada
• Mexico
• Europe
• France
• United Kingdom
• Italy
• Germany
• Spain
• Asia-Pacific
• China
• India
• Japan
• Australia
• South Korea
• South America
• Brazil
• Argentina
• Colombia
• Middle East & Africa
• South Africa
• Saudi Arabia
• UAE

Competitive Landscape

The report provides detailed profiles and strategic insights for leading companies operating in the Global Point of Care Coagulation Testing Devices Market. Analysis includes product innovation, market positioning, technological advancements, and global footprint.

Available Customizations

TechSci Research offers customizable elements in this report to align with specific business needs. Available options include:

• In-depth analysis and profiling of up to five additional market players

Let me know if you'd like this version adapted into a presentation deck, executive summary, or slide notes for a meeting!

Table of Contents

1. Product Overview

• 1.1. Market Definition
• 1.2. Scope of the Market
  • 1.2.1. Markets Covered
  • 1.2.2. Years Considered for Study
  • 1.2.3. Key Market Segmentations

2. Research Methodology

• 2.1. Objective of the Study
• 2.2. Baseline Methodology
• 2.3. Key Industry Partners
• 2.4. Major Association and Secondary Sources
• 2.5. Forecasting Methodology
• 2.6. Data Triangulation & Validation
• 2.7. Assumptions and Limitations

3. Executive Summary

• 3.1. Overview of the Market
• 3.2. Overview of Key Market Segmentations
• 3.3. Overview of Key Market Players
• 3.4. Overview of Key Regions/Countries
• 3.5. Overview of Market Drivers, Challenges, and Trends

4. Voice of Customer

5. Global Point of Care Coagulation Testing Devices Market Outlook

• 5.1. Market Size & Forecast
  • 5.1.1. By Value
• 5.2. Market Share & Forecast
  • 5.2.1. By Device Type (Anticoagulation Monitoring Devices, Platelet Function Monitoring Devices, Viscoelastic Coagulation Monitoring Devices, Others)
  • 5.2.2. By Product (Instruments/Analyzers, Consumables & Accessories)
  • 5.2.3. By End User (Hospitals, Clinics, Home Care Settings, Others)
  • 5.2.4. By Company (2024)
  • 5.2.5. By Region
• 5.3. Market Map

6. North America Point of Care Coagulation Testing Devices Market Outlook

• 6.1. Market Size & Forecast
  • 6.1.1. By Value
• 6.2. Market Share & Forecast
  • 6.2.1. By Device Type
  • 6.2.2. By Product
  • 6.2.3. By End User
  • 6.2.4. By Country
• 6.3. North America: Country Analysis
  • 6.3.1. United States Point of Care Coagulation Testing Devices Market Outlook
    • 6.3.1.1. Market Size & Forecast
      • 6.3.1.1.1. By Value
    • 6.3.1.2. Market Share & Forecast
      • 6.3.1.2.1. By Device Type
      • 6.3.1.2.2. By Product
      • 6.3.1.2.3. By End User
  • 6.3.2. Mexico Point of Care Coagulation Testing Devices Market Outlook
    • 6.3.2.1. Market Size & Forecast
      • 6.3.2.1.1. By Value
    • 6.3.2.2. Market Share & Forecast
      • 6.3.2.2.1. By Device Type
      • 6.3.2.2.2. By Product
      • 6.3.2.2.3. By End User
  • 6.3.3. Canada Point of Care Coagulation Testing Devices Market Outlook
    • 6.3.3.1. Market Size & Forecast
      • 6.3.3.1.1. By Value
    • 6.3.3.2. Market Share & Forecast
      • 6.3.3.2.1. By Device Type
      • 6.3.3.2.2. By Product
      • 6.3.3.2.3. By End User

7. Europe Point of Care Coagulation Testing Devices Market Outlook

• 7.1. Market Size & Forecast
  • 7.1.1. By Value
• 7.2. Market Share & Forecast
  • 7.2.1. By Device Type
  • 7.2.2. By Product
  • 7.2.3. By End User
  • 7.2.4. By Country
• 7.3. Europe: Country Analysis
  • 7.3.1. France Point of Care Coagulation Testing Devices Market Outlook
    • 7.3.1.1. Market Size & Forecast
      • 7.3.1.1.1. By Value
    • 7.3.1.2. Market Share & Forecast
      • 7.3.1.2.1. By Device Type
      • 7.3.1.2.2. By Product
      • 7.3.1.2.3. By End User
  • 7.3.2. Germany Point of Care Coagulation Testing Devices Market Outlook
    • 7.3.2.1. Market Size & Forecast
      • 7.3.2.1.1. By Value
    • 7.3.2.2. Market Share & Forecast
      • 7.3.2.2.1. By Device Type
      • 7.3.2.2.2. By Product
      • 7.3.2.2.3. By End User
  • 7.3.3. United Kingdom Point of Care Coagulation Testing Devices Market Outlook
    • 7.3.3.1. Market Size & Forecast
      • 7.3.3.1.1. By Value
    • 7.3.3.2. Market Share & Forecast
      • 7.3.3.2.1. By Device Type
      • 7.3.3.2.2. By Product
      • 7.3.3.2.3. By End User
  • 7.3.4. Italy Point of Care Coagulation Testing Devices Market Outlook
    • 7.3.4.1. Market Size & Forecast
      • 7.3.4.1.1. By Value
    • 7.3.4.2. Market Share & Forecast
      • 7.3.4.2.1. By Device Type
      • 7.3.4.2.2. By Product
      • 7.3.4.2.3. By End User
  • 7.3.5. Spain Point of Care Coagulation Testing Devices Market Outlook
    • 7.3.5.1. Market Size & Forecast
      • 7.3.5.1.1. By Value
    • 7.3.5.2. Market Share & Forecast
      • 7.3.5.2.1. By Device Type
      • 7.3.5.2.2. By Product
      • 7.3.5.2.3. By End User

8. Asia-Pacific Point of Care Coagulation Testing Devices Market Outlook

• 8.1. Market Size & Forecast
  • 8.1.1. By Value
• 8.2. Market Share & Forecast
  • 8.2.1. By Device Type
  • 8.2.2. By Product
  • 8.2.3. By End User
  • 8.2.4. By Country
• 8.3. Asia-Pacific: Country Analysis
  • 8.3.1. China Point of Care Coagulation Testing Devices Market Outlook
    • 8.3.1.1. Market Size & Forecast
      • 8.3.1.1.1. By Value
    • 8.3.1.2. Market Share & Forecast
      • 8.3.1.2.1. By Device Type
      • 8.3.1.2.2. By Product
      • 8.3.1.2.3. By End User
  • 8.3.2. India Point of Care Coagulation Testing Devices Market Outlook
    • 8.3.2.1. Market Size & Forecast
      • 8.3.2.1.1. By Value
    • 8.3.2.2. Market Share & Forecast
      • 8.3.2.2.1. By Device Type
      • 8.3.2.2.2. By Product
      • 8.3.2.2.3. By End User
  • 8.3.3. South Korea Point of Care Coagulation Testing Devices Market Outlook
    • 8.3.3.1. Market Size & Forecast
      • 8.3.3.1.1. By Value
    • 8.3.3.2. Market Share & Forecast
      • 8.3.3.2.1. By Device Type
      • 8.3.3.2.2. By Product
      • 8.3.3.2.3. By End User
  • 8.3.4. Japan Point of Care Coagulation Testing Devices Market Outlook
    • 8.3.4.1. Market Size & Forecast
      • 8.3.4.1.1. By Value
    • 8.3.4.2. Market Share & Forecast
      • 8.3.4.2.1. By Device Type
      • 8.3.4.2.2. By Product
      • 8.3.4.2.3. By End User
  • 8.3.5. Australia Point of Care Coagulation Testing Devices Market Outlook
    • 8.3.5.1. Market Size & Forecast
      • 8.3.5.1.1. By Value
    • 8.3.5.2. Market Share & Forecast
      • 8.3.5.2.1. By Device Type
      • 8.3.5.2.2. By Product
      • 8.3.5.2.3. By End User

9. South America Point of Care Coagulation Testing Devices Market Outlook

• 9.1. Market Size & Forecast
  • 9.1.1. By Value
• 9.2. Market Share & Forecast
  • 9.2.1. By Device Type
  • 9.2.2. By Product
  • 9.2.3. By End User
  • 9.2.4. By Country
• 9.3. South America: Country Analysis
  • 9.3.1. Brazil Point of Care Coagulation Testing Devices Market Outlook
    • 9.3.1.1. Market Size & Forecast
      • 9.3.1.1.1. By Value
    • 9.3.1.2. Market Share & Forecast
      • 9.3.1.2.1. By Device Type
      • 9.3.1.2.2. By Product
      • 9.3.1.2.3. By End User
  • 9.3.2. Argentina Point of Care Coagulation Testing Devices Market Outlook
    • 9.3.2.1. Market Size & Forecast
      • 9.3.2.1.1. By Value
    • 9.3.2.2. Market Share & Forecast
      • 9.3.2.2.1. By Device Type
      • 9.3.2.2.2. By Product
      • 9.3.2.2.3. By End User
  • 9.3.3. Colombia Point of Care Coagulation Testing Devices Market Outlook
    • 9.3.3.1. Market Size & Forecast
      • 9.3.3.1.1. By Value
    • 9.3.3.2. Market Share & Forecast
      • 9.3.3.2.1. By Device Type
      • 9.3.3.2.2. By Product
      • 9.3.3.2.3. By End User

10. Middle East and Africa Point of Care Coagulation Testing Devices Market Outlook

• 10.1. Market Size & Forecast
  • 10.1.1. By Value
• 10.2. Market Share & Forecast
  • 10.2.1. By Device Type
  • 10.2.2. By Product
  • 10.2.3. By End User
  • 10.2.4. By Country
• 10.3. MEA: Country Analysis
  • 10.3.1. South Africa Point of Care Coagulation Testing Devices Market Outlook
    • 10.3.1.1. Market Size & Forecast
      • 10.3.1.1.1. By Value
    • 10.3.1.2. Market Share & Forecast
      • 10.3.1.2.1. By Device Type
      • 10.3.1.2.2. By Product
      • 10.3.1.2.3. By End User
  • 10.3.2. Saudi Arabia Point of Care Coagulation Testing Devices Market Outlook
    • 10.3.2.1. Market Size & Forecast
      • 10.3.2.1.1. By Value
    • 10.3.2.2. Market Share & Forecast
      • 10.3.2.2.1. By Device Type
      • 10.3.2.2.2. By Product
      • 10.3.2.2.3. By End User
  • 10.3.3. UAE Point of Care Coagulation Testing Devices Market Outlook
    • 10.3.3.1. Market Size & Forecast
      • 10.3.3.1.1. By Value
    • 10.3.3.2. Market Share & Forecast
      • 10.3.3.2.1. By Device Type
      • 10.3.3.2.2. By Product
      • 10.3.3.2.3. By End User

11. Market Dynamics

• 11.1. Drivers
• 11.2. Challenges

12. Market Trends & Developments

• 12.1. Merger & Acquisition (If Any)
• 12.2. Product Launches (If Any)
• 12.3. Recent Developments

13. Disruptions: Conflicts, Pandemics and Trade Barriers

14. Porters Five Forces Analysis

• 14.1. Competition in the Industry
• 14.2. Potential of New Entrants
• 14.3. Power of Suppliers
• 14.4. Power of Customers
• 14.5. Threat of Substitute Products

15. Competitive Landscape

• 15.1. F. Hoffmann-La Roche Ltd.
  • 15.1.1. Business Overview
  • 15.1.2. Company Snapshot
  • 15.1.3. Products & Services
  • 15.1.4. Financials (As Reported)
  • 15.1.5. Recent Developments
  • 15.1.6. Key Personnel Details
  • 15.1.7. SWOT Analysis
• 15.2. Abbott Laboratories
• 15.3. Werfen, S.A.
• 15.4. Siemens Healthineers
• 15.5. Helena Laboratories Corporation
• 15.6. Medtronic plc
• 15.7. Koninklijke Philips N.V.
• 15.8. Alere Inc.
• 15.9. HemoSonics, LLC
• 15.10. Sysmex Corporation

16. Strategic Recommendations

17. About Us & Disclaimer